Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2280]
News [5219]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
Advances in prostate cancer - a decade in review
Dr Karim Fizazi, Dr Cora Sternberg, Dr John Fitzpatrick, Dr Heather Payne, Dr...
Advances in prostate cancer - a decade in review ( Dr Karim Fizazi, Dr Cora Sternberg, Dr John Fitzpatrick, Dr Heather Payne, Dr Peter Nelson )
30 Jan 2014
Dissecting the biology of the androgen receptor pathway
Dr Peter Nelson - Fred Hutchinson Cancer Research Center, Seattle, USA
Dissecting the biology of the androgen receptor pathway ( Dr Peter Nelson - Fred Hutchinson Cancer Research Center, Seattle, USA )
30 Jan 2014
mCRPC: Challenges and opportunities in a booming area
Dr Nicolas Mottet - University Hospital, Saint-Étienne, France
mCRPC: Challenges and opportunities in a booming area ( Dr Nicolas Mottet - University Hospital, Saint-Étienne, France )
10 Jan 2014
Managing mCRPC in daily practice: a pragmatic approach
Dr Alison Birtle - Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK
Managing mCRPC in daily practice: a pragmatic approach ( Dr Alison Birtle - Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK )
10 Jan 2014
Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel...
J.M. Fitzpatrick, N. Mottet, R. de Wit, Rotterdam and A Birtle
Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel discussion ( J.M. Fitzpatrick, N. Mottet, R. de Wit, Rotterdam and A Birtle )
10 Jan 2014
Rituximab maintenance therapy and CLL treatment considerations going forward
Prof Ulrich Jäger - Medical University of Vienna, Austria
Rituximab maintenance therapy and CLL treatment considerations going forward ( Prof Ulrich Jäger - Medical University of Vienna, Austria )
1 Jan 2014
Trial results at ASH 2013
Prof Ian Flinn - Sarah Cannon Cancer Center, Nashville, Tennessee, USA
Trial results at ASH 2013 ( Prof Ian Flinn - Sarah Cannon Cancer Center, Nashville, Tennessee, USA )
1 Jan 2014
Translational studies of CDK and PARP inhibitors
Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA
Translational studies of CDK and PARP inhibitors ( Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA )
19 Dec 2013
HER2 positive breast cancer treatment, past and future
Dr Edith Perez - Mayo Clinic, Rochester, USA
HER2 positive breast cancer treatment, past and future ( Dr Edith Perez - Mayo Clinic, Rochester, USA )
19 Dec 2013
Moving breast cancer stem cell therapies to the clinic
Dr Max Wicha - University of Michigan, Ann Arbor, USA
Moving breast cancer stem cell therapies to the clinic ( Dr Max Wicha - University of Michigan, Ann Arbor, USA )
19 Dec 2013
PIK3CA mutation predicts resistance to anti-HER2 treatment and chemotherapy
Dr Sibylle Loibl - German Breast Cancer Group
PIK3CA mutation predicts resistance to anti-HER2 treatment and chemotherapy ( Dr Sibylle Loibl - German Breast Cancer Group )
19 Dec 2013
Where to next for the elderly with acute myeloid leukaemia?
Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert...
Where to next for the elderly with acute myeloid leukaemia? ( Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert Ossenkoppele - VU University Medical Center, Amsterdam, Netherlands )
19 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation